Efficacy and safety of dapagliflozin in a dose-ranging monotherapy study of treatment-naive patients with type 2 diabetes

被引：0
|
作者：
List, J. F. [1 ]
Woo, V. [2 ]
Morales, E. [3 ]
Tang, W. [1 ]
Fiedorek, F. T. [1 ]
机构：
[1] Bristol Myers Squibb Co, Princeton, NJ USA
[2] Hlth Sci Ctr, Diabet Res & Treatment Ctr, Winnipeg, MB, Canada
[3] Ctr Invest Cardiometab, Aguascalientes, Mexico
来源：
DIABETOLOGIA | 2008年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
40
引用
收藏
页码：S22 / S23
页数：2
相关论文
共 50 条
  • [41] Efficacy and Safety of Dapagliflozin in Patients with Type 2 Diabetes on Insulin ± Metformin Regimens
    Katz, Arie
    Yeh, Helen
    DIABETES, 2015, 64 : A317 - A317
  • [42] Efficacy and safety of dapagliflozin in patients with type 2 diabetes and concomitant heart failure
    Kosiborod, Mikhail
    Gause-Nilsson, Ingrid
    Xu, John
    Sonesson, Christian
    Johnsson, Eva
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (07) : 1215 - 1221
  • [43] Efficacy and safety of sitagliptin monotherapy in Japanese patients with type 2 diabetes
    Nonaka, Kenji
    Kakikawa, Taro
    Sato, Asako
    Okuyama, Kotoba
    Fujimoto, Go
    Kato, Naoki
    Suzuki, Hideyo
    Hirayama, Yukio
    Ahmed, Tuli
    Davies, Michael J.
    Stein, Peter P.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 (02) : 291 - 298
  • [44] Dose-ranging study of the safety and pharmacokinetics of atrasentan in patients with refractory malignancies
    Ryan, CW
    Vogelzang, NJ
    Vokes, EE
    Kindler, HL
    Undevia, SD
    Humerickhouse, R
    André, AK
    Wang, Q
    Carr, RA
    Ratain, MJ
    CLINICAL CANCER RESEARCH, 2004, 10 (13) : 4406 - 4411
  • [45] Efficacy and safety of dapagliflozin treatment for type 2 diabetes mellitus patients with comorbid cardiovascular disease and hypertension
    Cefalu, W.
    Leiter, L.
    De Bruin, T.
    Gause-Nilsson, I.
    Sugg, J.
    Parikh, S.
    DIABETOLOGIA, 2012, 55 : S305 - S305
  • [46] Efficacy and Safety of Indacaterol, a New 24-hour 2-Agonist, in Patients with Asthma: A Dose-Ranging Study
    Kanniess, Frank
    Boulet, Louis-Philippe
    Pierzchala, Wladyslaw
    Cameron, Ray
    Owen, Roger
    Higgins, Mark
    JOURNAL OF ASTHMA, 2008, 45 (10) : 887 - 892
  • [47] Efficacy and safety of dapagliflozin plus saxagliptin vs monotherapy as added to metformin in patients with type 2 diabetes A meta-analysis
    Zhuang, Yan
    Song, Jin
    Ying, Miaofa
    Li, Mingxing
    MEDICINE, 2020, 99 (30) : E21409
  • [48] Efficacy and tolerability of vildagliptin monotherapy in drug-naive patients with type 2 diabetes
    Pi-Sunyer, F. Xavier
    Schweizer, Anja
    Mills, David
    Dejager, Sylvie
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 76 (01) : 132 - 138
  • [49] Safety and efficacy of fixed-dose combination of dapagliflozin and saxagliptin in patients with type 2 diabetes mellitus - a phase 4 study in India
    Wangnoo, S. K.
    Bhadada, Sanjay Kumar
    Farishta, Faraz
    Naidu, Girithara Gopalakrishnan Jayaram
    Pattnaik, Indira
    Manohar, K. N.
    Singh, K. P.
    Gupta, Sandeep Kumar
    Bharath, H. S.
    Ghosh, Sujoy
    FRONTIERS IN ENDOCRINOLOGY, 2025, 16
  • [50] The efficacy and safety of the dipeptidyl peptidase-4 inhibitor saxagliptin in treatment-naive patients with type 2 diabetes mellitus: a randomized controlled trial
    Frederich, Robert
    McNeill, Robert
    Berglind, Niklas
    Fleming, Douglas
    Chen, Roland
    DIABETOLOGY & METABOLIC SYNDROME, 2012, 4
12345